Dec. 30: Looking Back, Moving Forward: The Year in Treatment News
	Now more than 25 years since the 1983 discovery of HIV as the cause of AIDS, research continues at a steady clip in pursuit of sound prevention strategies, better treatments and—with a little bit of luck—a cure. While 2008 wasn’t exactly a year of earth-shattering discoveries, there were advances, setbacks and a few telltale hints of interesting things to come in 2009. Here we review the top 10 treatment research developments that made us sit up straight during the past 12 months.

	Dec. 16: Undetectable or Bust: Reevaluating Prolonged Hep C Treatment
	The goal of hepatitis C virus (HCV) treatment is to drop-kick HCV levels to undetectable while on interferon and ribavirin therapy for a year and maintain it for six months after treatment stops. But this only occurs in a minority of people coinfected with HIV and HCV. While it was originally believed that continued treatment might help protect the liver, a large clinical trial suggests that interferon maintenance therapy yields no additional benefit—or does it?

	Dec. 3: POZ Podium: Vanquishing AIDS: Notes on Ending the Epidemic in America
	On the occasion of World AIDS Day, a top AIDS doctor in NYC weighs in on the factors contributing to AIDS stigma, 27 years into the epidemic.

	Dec. 2: Path to a Cure? The Risk and Promise of Gene Therapy
	Recent news about a possible cure for HIV in a stem cell transplant patient could jump-start the related field of gene therapy. Stem cell expert Dr. David Scadden talks about the risks and the hopes that are moving researchers forward.

	Nov. 24: AIDS Advocates Debate Obama's Policies
	Leaders in the HIV/AIDS community commend President-elect Barack Obama’s pledge for a national AIDS strategy, but call on him to honor that commitment during his first 100 days in office.